DCM
NAMSW icon

Dupont Capital Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Dupont Capital Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,333
Closed -$6.67K – 1045
2022
Q4 		$6.67K Buy
+8,333
New +$6.86K ﹤0.01% 1174

Other funds holding NAMSW

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Dupont Capital Management's NAMSW Position: Q1 2023 in Review

Dupont Capital Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2023, closing a stake of 8,333 shares — an estimated $6.67K sold.

Dupont Capital Management first reported a position in NAMSW in Q4 2022 and held it in 1 quarter. The position peaked at $6.67K in Q4 2022. 18 funds tracked by Wall St. Rank hold NAMSW as of Q1 2023.

  • Dupont Capital Management reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 8,333 NewAmsterdam Pharma Warrant shares in Q1 2023, an estimated $6.67K.
  • Dupont Capital Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 1 quarter.
  • Dupont Capital Management's NewAmsterdam Pharma Warrant position peaked at $6.67K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.